These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 22187634

  • 21. Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation.
    Dioguardi Burgio M, Ronot M, Bruno O, Francoz C, Paradis V, Castera L, Durand F, Soubrane O, Vilgrain V.
    Liver Transpl; 2016 Nov; 22(11):1491-1500. PubMed ID: 27543821
    [Abstract] [Full Text] [Related]

  • 22. Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma.
    Ha Y, Han S, Shim JH, Ko GY, Yoon HK, Sung KB, Lee D, Kim KM, Lim YS, Chung YH, Lee YS, Lee HC.
    J Vasc Interv Radiol; 2015 Aug; 26(8):1093-1101.e1. PubMed ID: 26077020
    [Abstract] [Full Text] [Related]

  • 23. Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.
    Riaz A, Miller FH, Kulik LM, Nikolaidis P, Yaghmai V, Lewandowski RJ, Mulcahy MF, Ryu RK, Sato KT, Gupta R, Wang E, Baker T, Abecassis M, Benson AB, Nemcek AA, Omary R, Salem R.
    JAMA; 2010 Mar 17; 303(11):1062-9. PubMed ID: 20233824
    [Abstract] [Full Text] [Related]

  • 24. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ, Rochon PJ, Chang S, Ray CE, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J.
    J Vasc Interv Radiol; 2013 Nov 17; 24(11):1613-22. PubMed ID: 24060436
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS.
    J Vasc Interv Radiol; 2014 Feb 17; 25(2):256-65. PubMed ID: 24461131
    [Abstract] [Full Text] [Related]

  • 27. The true role of mRECIST guideline: does it really estimate viable tumor or merely improve accuracy in hepatocellular carcinoma response evaluation?
    Liu Q, Li A, Sun S, Luo R, Chen F.
    J BUON; 2014 Feb 17; 19(2):398-405. PubMed ID: 24965398
    [Abstract] [Full Text] [Related]

  • 28. mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib.
    Meyer T, Palmer DH, Cheng AL, Hocke J, Loembé AB, Yen CJ.
    Liver Int; 2017 Jul 17; 37(7):1047-1055. PubMed ID: 28066978
    [Abstract] [Full Text] [Related]

  • 29. Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses.
    Riaz A, Gabr A, Abouchaleh N, Ali R, Al Asadi A, Mora R, Kulik L, Desai K, Thornburg B, Mouli S, Hickey R, Miller FH, Yaghmai V, Ganger D, Lewandowski RJ, Salem R.
    Hepatology; 2018 Mar 17; 67(3):873-883. PubMed ID: 28833344
    [Abstract] [Full Text] [Related]

  • 30. A Modified Model for Assessment for Retreatment with Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients.
    Chen L, Ni CF, Chen SX, Cao JM, Zhu HD, Guo JH, Zhu GY, Zhong BY, Ding W, He SC, Deng G, Teng GJ.
    J Vasc Interv Radiol; 2016 Sep 17; 27(9):1288-1297. PubMed ID: 27013402
    [Abstract] [Full Text] [Related]

  • 31. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G, Yao-jun Z, Min-shan C, Mei-xian C, Jun-ting H, Li X, Lau WY.
    Liver Int; 2014 Apr 17; 34(4):612-20. PubMed ID: 24028297
    [Abstract] [Full Text] [Related]

  • 32. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
    Nicolini D, Agostini A, Montalti R, Mocchegiani F, Mincarelli C, Mandolesi A, Robertson NL, Candelari R, Giovagnoni A, Vivarelli M.
    World J Gastroenterol; 2017 May 28; 23(20):3690-3701. PubMed ID: 28611522
    [Abstract] [Full Text] [Related]

  • 33. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT, Kim JH, Lee LS, Kim KA, Ko GY, Yoon HK, Sung KB, Gwon DI, Shin JH, Song HY.
    J Vasc Interv Radiol; 2011 Jul 28; 22(7):917-23. PubMed ID: 21571545
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
    Kokabi N, Ludwig JM, Camacho JC, Xing M, Mittal PK, Kim HS.
    J Vasc Interv Radiol; 2015 Dec 28; 26(12):1777-86. PubMed ID: 26603497
    [Abstract] [Full Text] [Related]

  • 38. Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization.
    Kim BK, Kim KA, Kim MJ, Park JY, Kim DY, Ahn SH, Han KH, Kim SU, Park MS.
    Dig Liver Dis; 2015 Aug 28; 47(8):682-8. PubMed ID: 25977216
    [Abstract] [Full Text] [Related]

  • 39. Watershed Hepatocellular Carcinomas: The Risk of Incomplete Response following Transhepatic Arterial Chemoembolization.
    Kothary N, Takehana C, Mueller K, Sullivan P, Tahvildari A, Sidhar V, Rosenberg J, Louie JD, Sze DY.
    J Vasc Interv Radiol; 2015 Aug 28; 26(8):1122-9. PubMed ID: 26091800
    [Abstract] [Full Text] [Related]

  • 40. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma?
    Shim JH, Park JW, Choi JI, Kim HB, Lee WJ, Kim CM.
    J Vasc Interv Radiol; 2009 Feb 28; 20(2):209-16. PubMed ID: 19084432
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.